Toxoplasmosis and neuropsychiatric diseases: Can serological studies establish a clear relationship?

Neurological Sciences

Volumn 34, Issue 4, 2013, Pages 417-425

  Fabiani, Silvia ^a   Pinto, Barbara ^a   Bruschi, Fabrizio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Parkinson's disease, serological studies; Schizophrenia; Schizophrenia spectrum disorders; Toxoplasma gondii

Indexed keywords

FLUPHENAZINE; HALOPERIDOL; RISPERIDONE; VALPROIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY TITER; CHOREOATHETOSIS; DEGENERATIVE DISEASE; DYSTONIA; ENCEPHALITIS; EXTRAPYRAMIDAL SYNDROME; FOLLOW UP; HEMIBALLISM; HEMIDYSTONIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENINGITIS; MENTAL DISEASE; MOOD DISORDER; MYOCLONUS; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PREVALENCE; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEROLOGY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANTIBODIES, PROTOZOAN; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PROTOZOAN PROTEINS; SEROLOGIC TESTS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84879691120     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-1197-4     Document Type: Review

References (77)

1. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965-1976
2. Dubey JP (2008) The history of Toxoplasma gondii: the first 100 years. J Eukaryot Microbiol 55:467-475
3. Flegr J, Preiss M, Klose J et al (2003) Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol 63:253-268
4. Zhu S, Guo MF, Feng QC et al (2007) Epidemiological evidences from China assume that psychiatric-related diseases may be associated with Toxoplasma gondii infection. Neuro Endocrinol Lett 28:115-120
5. Zhu S (2009) Psychosis may be associated with toxoplasmosis. Med Hypotheses 73:799-801
6. Halonen SK, Lyman WD, Chiu FC (1996) Growth and development of Toxoplasma gondii in human neurons and astrocytes. J Neuropathol Exp Neurol 55:1150-1156
7. Cotter DR, Pariante CM, Everall IP (2001) Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 55:585-595
8. Doyle C, Deakin JFW (2002) Fewer astrocytes in frontal cortex in schizophrenia, depression and bipolar disorder. Schizophr Res 53:106
9. Conejero-Goldberg C, Torrey EF, Yolken RH (2003) Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res 60:65-69
10. Horacek J, Flegr J, Tintera J et al (2001) Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: Voxel-based- morphometry (VBM) study. World J Biol Psychiatry, pp 1-9 (accessed online)
11. Henriquez SA, Brett R, Alexander J et al (2009) Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 16:122-133
12. Melamede R (2009) Parasitic brain infection, endocannabinoids and schizophrenia. Med Hypotheses 72:220-222
13. Yolken RH, Dickerson FB, Torrey EF (2009) Toxoplasma and schizophrenia. Parasite Immunol 31:706-715
14. Webster JP (2007) The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr Bull 33:752-756
15. Huber M, Kirchler E, Karner M et al (2007) Delusional parasitosis and the dopamine transporter. A new insight of etiology? Med Hypotheses 68:1351-1358
16. Hinze-Selch D, Dubener W, Eggert L et al (2007) A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr Bull 33:782-788
17. Miller MA, Gardner IA, Kreuder C et al (2002) Coastal freshwater runoff is a risk factor for Toxoplasma gondii infection of southern sea otters (Enhydra lutris nereis). Int J Parasitol 32:997-1006
18. Schwarcz R, Hunter CA (2007) Toxoplasma gondii and Schizophrenia: linkage through astrocyte-derived kynurenic acid? Schizophr Bull 33:652-653
19. Eljaschewitsch E, Witting A, Mawrin C et al (2006) The endocannabinoid anandamine protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49:67-69
20. Carruthers VB, Suzuki Y (2007) Effects of Toxoplasma gondii infection on the brain. Schizophr Bull 33:745-751
21. Peterson PK, Gekker G, Hu S et al (1993) Intracellular survival and multiplication of Toxoplasma gondii in astrocytes. J Infect Dis 168:1472-1478
22. Wang HL, Li QY, Shu C et al (2006) Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand 114:40-48
23. Remington JS, McLeod R, Thulliez P et al (2001) Toxoplasmosis. In: Remington JS, Klein JO (eds) Infectious diseases in the fetus and newborn infant. Saunders, Philadelphia, pp 205-346
24. Stanford CF, Connolly JH, Ellis WA et al (1990) Zoonotic infections in Northern Ireland farmers. Epidemiol Infect 105:565-570
25. Zhu S, Lin YQ, Wang SJ et al (2003) Contrast study on schizophrenia's toxoplasmosis infection rate. Zhongguo Min Kang Yi Xue Za Zhi 15:405-407
26. Kozar Z (1953) Studies of toxoplasmosis among the mentally sick. Bull Inst Marit Trop Med Gdansk 5:142-145
27. El-Sahn AA, Shatat HZ, Ghitany EM (2005) Seropositivity of toxoplasmosis in patients with schizophrenia. J Egypt Public Health Assoc 80:509-524
28. Alvarado-Esquivel C, Alanis-Quiñones OP, Arreola-Valenzuela MA et al (2006) Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis 6:178-184
29. Cetinkaya Z, Yazar S, Gecici O et al (2007) Anti-Toxoplasma gondii antibodies in patients with schizophrenia - preliminary findings in a Turkish sample. Schizophr Bull 33:789-791
30. Tamer GS, Dundar D, Yalug I et al (2008) The schizophrenia and Toxoplasma gondii connection: infectious, immune or both? Adv Ther 25:703-709
31. Mahmoud SS, Hasan MS (2009) Seroprevalence of toxoplasmosis among schizophrenic patients. Yemeni J Med Sci. www.ust.edu.ye, http://www.med.ust. edu.ye/Journal/Journal.htm
32. Daryani A, Sharif M, Hosseini SH et al (2010) Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran. Tropical Biomed 27:476-482
33. Hamidinejat H, Ghorbanpoor M, Hosseini H et al (2010) Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia. Int J Infect Dis 14:e978-e981
34. Alavarado-Esquivel C, Urbina-Álvarez JD, Estrada-Martínez S et al (2011) Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population. Parasitol Inter 60:151-155
35. Tedla Y, Shibre T, Ali O et al (2011) Serum antibodies to Toxoplasma gondii and Herpesviridae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J 49:211-220
36. Torrey EF, Bartko J, Lun Z-R et al (2007) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 33:729-736
37. Delgado GG (1979) Toxoplasmosis and mental disease. Cubana Med Trop 31:127-131
38. Delgado GG, Garcia LJ (1979) Reactivity of the intradermal test with toxoplasmosis in schizophrenic patients. Rev Cubana Med Trop 31:225-231
39. Yolken RH, Bachmann S, Rouslanova I et al (2001) Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis 32:842-844
40. Wang HL, Wang GH, Li QY et al (2008) Comparison of clinical symptoms between anti-Toxoplasma-seropositive and seronegative patients with schizophrenia. Wuhan Da Xu Xu Bao 29:106-109
41. Garrido JA, Redondo VP (1968) Toxoplasmosis y enfermedades mentales. Arch Neurobiol 31:161-172
42. Niebuhr DW, Millikan AM, Cowan DN et al (2008) Selected infectious agents and risk of schizophrenia among US military personnel. Am J Psychiatry 165:99-106
43. Amminger GP, McGorry PD, Berger GE et al (2007) Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiatry 61:1215-1217
44. Brown AS, Schaefer CA, Quesenberry CP Jr et al (2005) Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 162:767-773
45. Brown AS (2006) Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 32:200-202
46. Brown AS (2008) The risk for schizophrenia from childhood and adult infections. Am J Psychiatry 165:7-10
47. Brown AS (2009) Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry 166:683-690
48. Mortensen PB, Nørgaard-Pedersen B, Waltoft BL et al (2007) Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull 33:741-744
49. Mortensen PB, Nørgaard-Pedersen B, Waltoft BL et al (2007) Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 61:688-693
50. Brown AS, Derkits EJ (2010) Prenatal infection and schizophrenia: a review of epidemiological and translational studies. Am J Psychiatry 167:261-280
51. Brown AS, Patterson PH (2011) Maternal infection and schizophrenia: implications for prevention. Schizophr Bull 37:284-290
52. Fatemi SH (2005) Prenatal viral infection, brain development and schizophrenia. In: Fatemi SH (ed) Neuropsychiatric disorders and infection. Taylor and Francis, London
53. Stiles J, Jernigan TL (2010) The basics of brain development. Neuropsychol Rev 20:327-348
54. Paus T (2005) Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci 9:60-68
55. Keshavan MS (1999) Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 33:513-521
56. Keshavan MS, Hogarty GE (1999) Brain maturational processes and delayed onset in schizophrenia. Dev Psychopathol 11:525-543
57. Lipska BK, Weinberger DR (2000) To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23:223-239
58. Lipska BK, Aultman JM, Verma A et al (2002) Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27:47-54
59. Clarke MC, Tanskanen A, Huttunen M et al (2009) Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia. Am J Psychiatry 166:1025-1030
60. Stibbs HH (1985) Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 79:153-157
61. Dalman C, Allebeck P, Gunnell D et al (2008) Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry 165:59-65
62. Xiao J, Buka SL, Cannon TD et al (2009) Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect 11:1011-1018
63. Carrazana EJ, Rossitch E Jr, Samuels MA (1989) Parkinsonian symptoms in a patient with AIDS and cerebral toxoplasmosis. J Neurol Neurosurg Psychiatry 52:1445-1447
64. Noël S, Guillaume MP, Telemman-Toppet N et al (1992) Movement disorders due to cerebral Toxoplasma gondii infection in patients with the acquired immunodeficiency syndrome (AIDS). Acta Neurol Belg 92:148-156
65. Miman O, Kusbeci OY, Aktepe OC et al (2010) The probable relation between Toxoplasma gondii and Parkinson's disease. Neurosci Lett 475:129-131
66. Berger JR, Moskowitz L, Fischl M et al (1984) The neurologic complications of AIDS: frequently the initial manifestation. Neurology 34:134-135
67. Navia BA, Petito CK, Gold JW et al (1986) Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 19:224-238
68. Nath A, Jankovic J, Pettigrew LC (1987) Movement disorders and AIDS. Neurology 37:37-41
69. Mirsattari SM, Power C, Nath A (1988) Parkinsonism with HIV infection. Mov Disord 13:684-689
70. Hirose G (2000) Parkinsonism in a patient with AIDS. Intern Med 39:1006-1007
71. Maggi P, de Mari M, Moramarco A et al (2000) Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions. Neurol Sci 21:173-176
72. Murakami T, Nakajima M, Nakamura T et al (2000) Parkinsonian symptoms as an initial manifestation in a Japanese patient with acquired immunodeficiency syndrome and Toxoplasma infection. Internal Med 39:1111-1114
73. Mattos JP, de Rosso AL, Corrêa RB et al (2002) Movement disorders in 28 HIV-infected patients. Arq Neuropsiquiatr 60:525-530
74. Celik T, Kamisli O, Babür C et al (2010) Is there a relationship between Toxoplasma gondii infection and idiopathic Parkinson's disease? Scand J Infect Dis 42:604-608
75. Yolken RH, Torrey EF (2008) Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 13:470-479
76. Kusbeci OY, Miman O, Yaman M et al (2011) Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord 25:1-3
77. Ferguson DJP (2009) Toxoplasma gondii: 1908-2008, homage to Nicolle, Manceaux and Splendore. Mem Inst Oswaldo Cruz 104:133-148